The infection with the SARS-CoV-2 virus is associated with numerous systemic
involvements. Besides the severe respiratory injuries and cardiovascular complications, it …

The coronavirus SARS-CoV2 disease (COVID-19) is connected with significant morbidity
and mortality (3.4%), disorders in hemostasis, including coagulopathy, activation of platelets …

Abstract Background Coronavirus disease 2019 (COVID-19) induces inflammation,
autoantibody production, and thrombosis, which are common symptoms of autoimmune …

Background COVID-19 is known to be associated with a myriad of cardiovascular (CV)
complications during acute illness, but the rates of readmissions for CV complications after …

Objective To assess the rates of vascular thrombotic adverse events in the first 35 days after
one dose of the Ad26. COV2. S vaccine (Janssen/Johnson & Johnson) in healthcare …

Objective To study the association between COVID-19 vaccination and the risk of post-
COVID-19 cardiac and thromboembolic complications. Methods We conducted a staggered …

Introduction COVID‐19 is associated with an increased risk of venous thromboembolism
(VTE), but there is great variation among reported incidence rates. Most previous studies …

Unprovoked Venous Thromboembolism - Medical Clinics Skip to Main Content
Advertisement Medical Clinics Log in Register Log in Subscribe Claim Skip menu theclinics.com …

Background: Cardiovascular complications contribute to 40% of coronavirus disease 2019
(COVID-19) related deaths. The viral myocarditis associated with COVID-19 accounts for …

One aspect of COVID-19 (coronavirus disease 2019) that has now been clarified, is that
patients with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection …